Safety & Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy

See also
Status	Clinical Trial	Phase
Completed	`NCT04830371` - Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants	Phase 2/Phase 3
Recruiting	`NCT04543877` - WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study	Early Phase 1
Completed	`NCT02324751` - Vaccines Against Salmonella Typhi	Phase 2
Completed	`NCT01421693` - Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever	Phase 4
Completed	`NCT05579821` - Evaluation Study of DPP® Typhoid Assay
Completed	`NCT02947295` - Global Genomic and Proteomic Profiling of African Children With Typhoid Fever
Completed	`NCT01405521` - Understanding Typhoid Disease After Vaccination	Phase 2
Completed	`NCT00386789` - Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age	N/A
Completed	`NCT04801602` - Commercial Typhoid Tests Validation Trial
Recruiting	`NCT06104345` - Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines	Phase 4
Completed	`NCT01437267` - Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants	Phase 2
Completed	`NCT01438996` - Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults	Phase 2
Completed	`NCT01193907` - Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)	Phase 2
Recruiting	`NCT04349826` - The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)	Phase 4
Completed	`NCT01608815` - Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects	Phase 3
Completed	`NCT01123941` - Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)	Phase 1
Recruiting	`NCT05500482` - Vellore Typhoid Vaccine Impact Trial	Phase 4
Completed	`NCT03926455` - Safety and Immunogenicity of Typhax, a Typhoid Vaccine	Phase 1
Completed	`NCT01229176` - Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants	Phase 2
Completed	`NCT04154722` - Comparison of Two Drugs Regimen in Treatment of Complicated Typhoid Fever in Children	Phase 4

NCT number	NCT03956524
Study type	Interventional
Source	EuBiologics Co.,Ltd
Contact
Status	Completed
Phase	Phase 1
Start date	March 16, 2019
Completion date	August 31, 2019

Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms